Vestipitant and Vofopitant 2 Day PSG Study for Insomnia

Trial Profile

Vestipitant and Vofopitant 2 Day PSG Study for Insomnia

Completed
Phase of Trial: Phase II

Latest Information Update: 13 Jul 2017

At a glance

  • Drugs Vestipitant (Primary) ; Vofopitant (Primary)
  • Indications Insomnia
  • Focus Therapeutic Use
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 20 May 2009 Actual end date (May 2008) added as reported by ClinicalTrials.gov.
    • 27 Oct 2008 Planned end date changed from Sep 2008 to May 2008 as reported by Clinicaltrials.gov.
    • 27 Oct 2008 Trial phase changed from I to II as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top